BCAT1 and leukemia: Similarly, in EZH2 inactivated leukemia stem cells (LSC), the combined effect of the loss of EZH2 and NRAS enhance BCAT1-mediated BCAA metabolism and upregulated the expression of genes involved in TCA (e.g., IDH) [57] (Fig. 2).